180 related articles for article (PubMed ID: 35532982)
1. Executive Functioning in Pediatric Anxiety and Its Relationship to Selective Serotonin Reuptake Inhibitor Treatment Response: A Double-Blind, Placebo-Controlled Trial.
Baumel WT; Mills JA; Schroeder HK; Specht AM; Rothenberg R; Peris TS; Strawn JR
J Child Adolesc Psychopharmacol; 2022 May; 32(4):215-223. PubMed ID: 35532982
[No Abstract] [Full Text] [Related]
2. Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.
Lu L; Mills JA; Li H; Schroeder HK; Mossman SA; Varney ST; Cecil KM; Huang X; Gong Q; Ramsey LB; DelBello MP; Sweeney JA; Strawn JR
J Am Acad Child Adolesc Psychiatry; 2021 Oct; 60(10):1309-1318. PubMed ID: 33548492
[TBL] [Abstract][Full Text] [Related]
3. A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder.
Strawn JR; Moldauer L; Hahn RD; Wise A; Bertzos K; Eisenberg B; Greenberg E; Liu C; Gopalkrishnan M; McVoy M; Knutson JA
J Child Adolesc Psychopharmacol; 2023 Apr; 33(3):91-100. PubMed ID: 37074330
[No Abstract] [Full Text] [Related]
4. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
5. Acute neurofunctional effects of escitalopram during emotional processing in pediatric anxiety: a double-blind, placebo-controlled trial.
Lu L; Li H; Baumel WT; Mills JA; Cecil KM; Schroeder HK; Mossman SA; Huang X; Gong Q; Sweeney JA; Strawn JR
Neuropsychopharmacology; 2022 Apr; 47(5):1081-1087. PubMed ID: 34580419
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study.
Strawn JR; Mills JA; Schroeder H; Mossman SA; Varney ST; Ramsey LB; Poweleit EA; Desta Z; Cecil K; DelBello MP
J Clin Psychiatry; 2020 Aug; 81(5):. PubMed ID: 32857933
[TBL] [Abstract][Full Text] [Related]
7. Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.
Davidson JR; Bose A; Korotzer A; Zheng H
Depress Anxiety; 2004; 19(4):234-40. PubMed ID: 15274172
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.
Strawn JR; Prakash A; Zhang Q; Pangallo BA; Stroud CE; Cai N; Findling RL
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):283-93. PubMed ID: 25791145
[TBL] [Abstract][Full Text] [Related]
9. Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.
Lenze EJ; Rollman BL; Shear MK; Dew MA; Pollock BG; Ciliberti C; Costantino M; Snyder S; Shi P; Spitznagel E; Andreescu C; Butters MA; Reynolds CF
JAMA; 2009 Jan; 301(3):295-303. PubMed ID: 19155456
[TBL] [Abstract][Full Text] [Related]
10. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R
Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
[TBL] [Abstract][Full Text] [Related]
11. Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials.
Goodman WK; Bose A; Wang Q
J Affect Disord; 2005 Aug; 87(2-3):161-7. PubMed ID: 15982747
[TBL] [Abstract][Full Text] [Related]
12. Treatment-related alteration of cortisol predicts change in neuropsychological function during acute treatment of late-life anxiety disorder.
Lenze EJ; Dixon D; Mantella RC; Dore PM; Andreescu C; Reynolds CF; Newcomer JW; Butters MA
Int J Geriatr Psychiatry; 2012 May; 27(5):454-62. PubMed ID: 21681817
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
Strawn JR; Mills JA; Sauley BA; Welge JA
J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.
Davidson JR; Bose A; Wang Q
J Clin Psychiatry; 2005 Nov; 66(11):1441-6. PubMed ID: 16420082
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
Carter NJ; McCormack PL
CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
[TBL] [Abstract][Full Text] [Related]
17. Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder.
Stein DJ; Lopez AG
Adv Ther; 2011 Nov; 28(11):1021-37. PubMed ID: 22057726
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.
Rynn MA; Riddle MA; Yeung PP; Kunz NR
Am J Psychiatry; 2007 Feb; 164(2):290-300. PubMed ID: 17267793
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial.
Alaka KJ; Noble W; Montejo A; Dueñas H; Munshi A; Strawn JR; Lenox-Smith A; Ahl J; Bidzan L; Dorn B; Ball S
Int J Geriatr Psychiatry; 2014 Sep; 29(9):978-86. PubMed ID: 24644106
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
Stahl SM; Gergel I; Li D
J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
